Arvinas Inc (NASDAQ: ARVN) is -32.80% lower on its value in year-to-date trading and has touched a low of $14.02 and a high of $53.08 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ARVN stock was last observed hovering at around $27.50 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $27.66, the stock is 5.54% and 8.21% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing 0.58% at the moment leaves the stock -15.14% off its SMA200. ARVN registered 83.42% gain for a year compared to 6-month loss of -14.84%. The firm has a 50-day simple moving average (SMA 50) of $25.5618 and a 200-day simple moving average (SMA200) of $32.595.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.17% gain in the last 1 month and extending the period to 3 months gives it a 3.29%, and is 4.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.30% over the week and 4.98% over the month.
Arvinas Inc (ARVN) has around 445 employees, a market worth around $1.90B and $93.30M in sales. Profit margin for the company is -346.62%. Distance from 52-week low is 97.23% and -47.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.80%).
The EPS is expected to grow by 52.83% this year
300.0 institutions hold shares in Arvinas Inc (ARVN), with institutional investors hold 115.27% of the company’s shares. The shares outstanding are 68.00M, and float is at 59.43M with Short Float at 15.69%. Institutions hold 106.94% of the Float.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 6.73 million shares valued at $179.06 million. The investor’s holdings represent 9.3553 of the ARVN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 6.67 million shares valued at $177.6 million to account for 9.2793 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.26 million shares representing 8.7049 and valued at over $166.61 million, while PRICE T ROWE ASSOCIATES INC /MD/ holds 5.5478 of the shares totaling 3.99 million with a market value of $106.19 million.
Arvinas Inc (ARVN) Insider Activity
The most recent transaction is an insider sale by Houston John G, the company’s President and CEO. SEC filings show that Houston John G sold 5,196 shares of the company’s common stock on Feb 23 ’24 at a price of $47.05 per share for a total of $0.24 million. Following the sale, the insider now owns 1.04 million shares.
Arvinas Inc disclosed in a document filed with the SEC on Feb 23 ’24 that Cassidy Sean A (Chief Financial Officer) sold a total of 1,702 shares of the company’s common stock. The trade occurred on Feb 23 ’24 and was made at $47.05 per share for $80079.0. Following the transaction, the insider now directly holds 0.18 million shares of the ARVN stock.
Still, SEC filings show that on Feb 23 ’24, Peck Ronald (Chief Medical Officer) disposed off 1,699 shares at an average price of $47.05 for $79938.0. The insider now directly holds 67,516 shares of Arvinas Inc (ARVN).
